Key points are not available for this paper at this time.
Many workflows in Pharmaceutical R however, these existing technologies do not meet the requirements for every high-throughput experimentation powder dispensing application. A Working Group (WG) composed of pharmaceutical researchers within the Enabling Technologies Consortium (ETC) evaluated automated platforms commercially available from three manufacturers using an objective, systematic testing protocol. This paper describes the selection of powders and testing conditions used in this evaluation, and it assesses the impact that the powders, testing conditions, equipment environment, and other factors had on the performance of the selected platforms.
Bahr et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: